Cytochroma

About:

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat

Website: http://www.cytochroma.com

Top Investors: Novo Holdings, BDC Venture Capital, Caisse de Depot et Placement du Quebec, Business Development Bank of Canada, BDC Capital Corporation

Description:

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.